Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00896675 · ClinicalTrials.gov registry record

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

A clinical trial of Head and Neck Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
352
Enrollment target
3
Study locations

NCT00896675 is a study of Head and Neck Cancer that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 352 participants, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (36% higher). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00896675, a study of Head and Neck Cancer, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
352 participants
Enrollment target
3
Study locations

Study Summary

RATIONALE: Studying samples of blood in the laboratory may help doctors learn more about cancer. It may also help doctors predict how well patients will respond to treatment. PURPOSE: This research study is looking at proteins in blood samples to predict treatment benefit in patients with recurrent and/or metastatic squamous cell head and neck cancer.

Conditions Studied

Head and Neck Cancer

Interventions

  • OTHER proteomic profiles

Study Locations (3)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
  • Vanderbilt-Ingram Cancer Center at Franklin - Nashville
  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 352 participants
Start Date 2007-06
Est. Completion 2009-12

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00896675

The ClinicalTrials.gov registry entry for NCT00896675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (36% higher). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which proteomic profiles is the first listed.

NCT00896675 reports 3 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00896675 about?

NCT00896675 is a clinical study titled "Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer". RATIONALE: Studying samples of blood in the laboratory may help doctors learn more about cancer. It may also help doctors predict how well patients will respond to treatment. PURPOSE: This research study is looking at proteins in blood samples to predict treatment benefit in patients with recurrent...

What is the current status of trial NCT00896675?

This trial is currently completed. The enrollment target is 352 participants. The study started on 2007-06. Estimated completion is 2009-12.

What conditions does trial NCT00896675 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00896675?

The interventions under investigation include: proteomic profiles (OTHER).

Who is sponsoring clinical trial NCT00896675?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00896675 being conducted?

This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.